Continue to Limit Celecoxib and Other NSAIDs in High-CV-Risk Patients
November 2017
Debate will continue about whether it's okay to use celecoxib (Celebrex, etc) in patients at high cardiovascular risk.
All NSAIDs have a warning about CV risk. But we're used to thinking that COX-2 inhibitors are riskier...especially since rofecoxib (Vioxx) was withdrawn due to an increased risk of heart attacks and strokes.
But celecoxib's CV risk may not be higher than other NSAIDs.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote